Home

Acura pain pill meets goal in late-stage trial

By Associated Press
June 17, 2008 | Comments (0)

Recs

0

Acura Pharmaceuticals Inc. said Tuesday that it late-stage trial of its pain pill Acurox met its goal.

The drug contains the prescription pain drug oxycodone, but with other ingredients to deter abuse.

Under an agreement signed in October, King Pharmaceuticals Inc. has a license to commercialize the drug.

An Acurox application is expected to be submitted to the Food and Drug Administration by the end of the year.

Shares of Acura rose 15 cents to $9.21 in morning trading, while King shares rose 26 cents to $9.77.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

DocumentId: 666258, ~/articles/articlehandler.aspx, 12/2/2008 2:50:15 AM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.